Human and rat urinary metabolites of the antitumor drug Celiptium (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the "biooxidative alkylation" hypothesis.
D000470:Alkaloids / Q000652:urine*; D000478:Alkylation; D000818:Animals; D000970:Antineoplastic Agents / Q000652:urine*; D055598:Chemical Phenomena; D002621:Chemistry; D002851:Chromatography, High Pressure Liquid; D003545:Cysteine / Q000652:urine*; D004611:Ellipticines / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains
D000470:Alkaloids; D000970:Antineoplastic Agents; D004611:Ellipticines; C027767:elliptinium; D003545:Cysteine